Clove Oil-based Nanoemulsion Co-loaded With Saquinavir, Ritonavir and Acyclovir for Enhanced Oral Pharmacokinetics and Brain Exposure in Herpes Simplex Encephalitis and NeuroAIDS

Goswami S, Khan I, Malik A, Siddiqi NJ, Kaul M, Dhotre K, Khan AA, Mukherjee A, Kumar S (2026)


Publication Type: Journal article

Publication year: 2026

Journal

Book Volume: 37

Article Number: 137

Journal Issue: 6

DOI: 10.1007/s10876-026-03093-0

Abstract

The management of Herpes simplex virus (HSV) and human immunodeficiency virus (HIV) co-infection is severely hindered by the poor oral bioavailability and restricted blood-brain barrier (BBB) penetration of conventional antiviral therapies. In this study, a novel triple drug-loaded nanoemulsion containing saquinavir (SQV), ritonavir (RTV) and acyclovir (ACV) was developed and optimized using a Central Composite Rotatable Design (CCRD) to enhance systemic absorption and brain exposure. The formulation was prepared via ultrasonication and characterized for droplet size, zeta potential, and rheological properties. The optimized nanoemulsion exhibited favorable physicochemical characteristics, including nanometric droplet size, acceptable size distribution, high transparency, and good stability. In vitro release (p < 0.0001) and ex vivo permeation studies (p < 0.05) demonstrated significantly higher drug flux compared to the drug suspension. Pharmacokinetic profiling in Wistar rats confirmed a prominent increase in systemic exposure (p < 0.001). The nanoemulsion also significantly increased drug concentrations in brain tissue compared with the corresponding suspension formulation (p < 0.001), indicating enhanced brain exposure of all three antiviral agents. These findings suggest that the triple drug-loaded nanoemulsion represents a promising oral delivery platform improves the pharmacokinetic performance and brain exposure of antiviral agents, with potential application in the management of HIV-1 and HSV co-infections.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Goswami, S., Khan, I., Malik, A., Siddiqi, N.J., Kaul, M., Dhotre, K.,... Kumar, S. (2026). Clove Oil-based Nanoemulsion Co-loaded With Saquinavir, Ritonavir and Acyclovir for Enhanced Oral Pharmacokinetics and Brain Exposure in Herpes Simplex Encephalitis and NeuroAIDS. Journal of Cluster Science, 37(6). https://doi.org/10.1007/s10876-026-03093-0

MLA:

Goswami, Sahil, et al. "Clove Oil-based Nanoemulsion Co-loaded With Saquinavir, Ritonavir and Acyclovir for Enhanced Oral Pharmacokinetics and Brain Exposure in Herpes Simplex Encephalitis and NeuroAIDS." Journal of Cluster Science 37.6 (2026).

BibTeX: Download